General developmental health in the VPA-rat model of autism

Frontiers in Behavioral Neuroscience

Volumn , Issue JUL, 2013, Pages

  Favre, Mônica Regina ^a   Barkat, Tania Rinaldi ^b   LaMendola, Deborah ^a   Khazen, Georges ^c   Markram, Henry ^a   Markram, Kamila ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

Animal model; Autism; Development; Rat; Teratogen; Valproic acid; VPA

Indexed keywords

VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR; BODY WEIGHT; BRAIN WEIGHT; CHROMODACRYORRHEA; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEVELOPMENT; DISEASE MODEL; FEMALE; LACRIMATION DISORDER; LITTER SIZE; MALE; NONHUMAN; OLFACTORY DISCRIMINATION; PERINATAL PERIOD; PROGENY; RAT; WEIGHT GAIN;

EID: 84879701809     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00088     Document Type: Article

References (101)

1. Arndt, T. L., Stodgell, C. J. and Rodier, P. M. (2005). "The teratology of autism. " Int J Dev Neurosci 23(2-3): 189-199.
2. Bambini-Junior, V., Rodrigues, L., Behr, G. A., Moreira, J. C., Riesgo, R. and Gottfried, C. (2011). "Animal model of autism induced by prenatal exposure to valproate: Behavioral changes and liver parameters. " Brain Res 1408: 8-16.
3. Bandim, J. M., Ventura, L. O., Miller, M. T., Almeida, H. C. and Costa, A. E. (2003). "Autism and mobius sequence: An exploratory study of children in northeastern brazil. " Arq Neuropsiquiatr 61(2A): 181-185.
4. Bernier, R., Dawson, G., Panagiotides, H. and Webb, S. (2005). "Individuals with autism spectrum disorder show normal responses to a fear potential startle paradigm. " J Autism Dev Disord 35(5): 575-583.
5. Betancur, C. (2011). "Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. " Brain Res 1380: 42-77.
6. Binkerd, P. E., Rowland, J. M., Nau, H. and Hendrickx, A. G. (1988). "Evaluation of valproic acid (vpa) developmental toxicity and pharmacokinetics in sprague-dawley rats. " Fundam Appl Toxicol 11(3): 485-493.
7. Burn, C. C., Peters, A., Day, M. J. and Mason, G. J. (2006). "Long-term effects of cage-cleaning frequency and bedding type on laboratory rat health, welfare, and handleability: A cross-laboratory study. " Lab Anim 40(4): 353-370.
8. Casanova, M. F. (2007). "The neuropathology of autism. " Brain Pathol 17(4): 422-433.
9. Castelhano-Carlos, M. J. and Baumans, V. (2009). "The impact of light, noise, cage cleaning and in-house transport on welfare and stress of laboratory rats. " Laboratory Animals 43(4): 311-327.
10. Chapman, J. B. and Cutler, M. G. (1984). "Sodium valproate: Effects on social behaviour and physical development in the mouse. " Psychopharmacology (Berl) 83(4): 390-396.
11. Chess, S. (1971). "Autism in children with congenital rubella. " J Autism Child Schizophr 1(1): 33-47.
12. Chomiak, T. and Hu, B. (2012). "Alterations of neocortical development and maturation in autism: Insight from valproic acid exposure and animal models of autism. " Neurotoxicol Teratol.
13. Chomiak, T., Karnik, V., Block, E. and Hu, B. (2010). "Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism. " BMC Neurosci 11: 102.
14. Christensen, J., Gronborg, T. K., Sorensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H. and Vestergaard, M. (2013). "Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. " JAMA 309(16): 1696-1703.
15. Clayton-Smith, J. and Donnai, D. (1995). "Fetal valproate syndrome. " J Med Genet 32(9): 724-727.
16. Courchesne, E., Campbell, K. and Solso, S. (2011). "Brain growth across the life span in autism: Age-specific changes in anatomical pathology. " Brain Res 1380: 138-145.
17. dos Reis, E. R., Nicola, E. M. D. and Nicola, J. H. (2005). "Harderian gland of wistar rats revised as a protoporphyrin ix producer. " Braz. J. morphol. Sci 22(1): 43-51.
18. Dufour-Rainfray, D., Vourc'h, P., Le Guisquet, A. M., Garreau, L., Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C., Andres, C. R., Chalon, S. and Guilloteau, D. (2010). "Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism. " Neurosci Lett 470(1): 55-59.
19. Emond, A., Emmett, P., Steer, C. and Golding, J. (2010). "Feeding symptoms, dietary patterns, and growth in young children with autism spectrum disorders. " Pediatrics 126(2): e337-342.
20. Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E. and Taga, K. (2005). "The fears, phobias and anxieties of children with autism spectrum disorders and down syndrome: Comparisons with developmentally and chronologically age matched children. " Child Psychiatry Hum Dev 36(1): 3-26.
21. Evans, E. W., Must, A., Anderson, S. E., Curtin, C., Scampini, R., Maslin, M. and Bandini, L. (2012). "Dietary patterns and body mass index in children with autism and typically developing children. " Res Autism Spectr Disord 6(1): 399-405.
22. Foley, A. G., Gannon, S., Rombach-Mullan, N., Prendergast, A., Barry, C., Cassidy, A. W. and Regan, C. M. (2012). "Class i histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder. " Neuropharmacology 63(4): 750-760.
23. Folsom, T. D. and Hossein Fatemi, S. (2012). "The involvement of reelin in neurodevelopmental disorders. " Neuropharmacology.
24. Fombonne, E. (2009). "Epidemiology of pervasive developmental disorders. " Pediatr Res 65(6): 591-598.
25. Frisch, C., Husch, K., Angenstein, F., Kudin, A., Kunz, W., Elger, C. E. and Helmstaedter, C. (2009). "Dose-dependent memory effects and cerebral volume changes after in utero exposure to valproate in the rat. " Epilepsia 50(6): 1432-1441.
26. Gaigg, S. B. and Bowler, D. M. (2007). "Differential fear conditioning in asperger's syndrome: Implications for an amygdala theory of autism. " Neuropsychologia 45(9): 2125-2134.
27. Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. and Siegel, S. J. (2010). "Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism. " Biol Psychiatry 68(12): 1100-1106.
28. Go, H. S., Kim, K. C., Choi, C. S., Jeon, S. J., Kwon, K. J., Han, S. H., Lee, J., Cheong, J. H., Ryu, J. H., Kim, C. H., Ko, K. H. and Shin, C. Y. (2012). "Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the gsk-3beta/beta-catenin pathway. " Neuropharmacology 63(6): 1028-1041.
29. Gonzales, M. L. and LaSalle, J. M. (2010). "The role of mecp2 in brain development and neurodevelopmental disorders. " Curr Psychiatry Rep 12(2): 127-134.
30. Haddad, P. M., Das, A., Ashfaq, M. and Wieck, A. (2009). "A review of valproate in psychiatric practice. " Expert Opin Drug Metab Toxicol 5(5): 539-551.
31. Hara, Y., Maeda, Y., Kataoka, S., Ago, Y., Takuma, K. and Matsuda, T. (2012). "Effect of prenatal valproic acid exposure on cortical morphology in female mice. " J Pharmacol Sci 118(4): 543-546.
32. Harkness, J. E. and Ridgway, M. D. (1980). "Chromodacryorrhea in laboratory rats (rattus norvegicus): Etiologic considerations. " Lab Anim Sci 30(5): 841-844.
33. Hendrickx, A. G., Nau, H., Binkerd, P., Rowland, J. M., Rowland, J. R., Cukierski, M. J. and Cukierski, M. A. (1988). "Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: An interspecies comparison. " Teratology 38(4): 329-345.
34. Hofvander, B., Delorme, R., Chaste, P., Nyden, A., Wentz, E., Stahlberg, O., Herbrecht, E., Stopin, A., Anckarsater, H., Gillberg, C., Rastam, M. and Leboyer, M. (2009). "Psychiatric and psychosocial problems in adults with normalintelligence autism spectrum disorders. " BMC Psychiatry 9: 35.
35. Hugo, J., Krijt, J., Vokurka, M. and Janousek, V. (1987). "Secretory response to light in rat harderian gland: Possible photoprotective role of harderian porphyrin. " Gen Physiol Biophys 6(4): 401-404.
36. Ingram, J. L., Peckham, S. M., Tisdale, B. and Rodier, P. M. (2000). "Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. " Neurotoxicology and Teratology 22: 319-324.
37. Kaffman, A. and Krystal, J. H. (2012). "New frontiers in animal research of psychiatric illness. " Methods Mol Biol 829: 3-30.
38. Kalkman, H. O. (2012). "A review of the evidence for the canonical wnt pathway in autism spectrum disorders. " Mol Autism 3(1): 10.
39. Kanner, L. (1943). "Autistic disturbances of affective contact. " Nervous Child 2: 217-250.
40. Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y. and Matsuda, T. (2011). "Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. " Int J Neuropsychopharmacol: 1-13.
41. Kemper, T. L. and Bauman, M. (1998). "Neuropathology of infantile autism. " Journal of Neuropathology and Experimental Neurology 57: 645-652.
42. Kerins, C. A., Carlson, D. S., McIntosh, J. E. and Bellinger, L. L. (2003). "Meal pattern changes associated with temporomandibular joint inflammation/pain in rats; analgesic effects. " Pharmacol Biochem Behav 75(1): 181-189.
43. Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Park, J. H., Kim, H. J., Jeon, S. J., Dela Pena, I. C., Han, S. H., Cheong, J. H., Ryu, J. H. and Shin, C. Y. (2013). "Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. " J Neurochem 124(6): 832-843.
44. Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Yang, S. I., Cheong, J. H., Shin, C. Y. and Ko, K. H. (2011). "The critical period of valproate exposure to induce autistic symptoms in sprague-dawley rats. " Toxicol Lett 201(2): 137-142.
45. Kini, U. (2006). "Fetal valproate syndrome: A review. " Paediatric and Perinatal Drug Therapy 7(3): 123-130.
46. Kolozsi, E., Mackenzie, R. N., Roullet, F. I., deCatanzaro, D. and Foster, J. A. (2009). "Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. " Neuroscience 163(4): 1201-1210.
47. Kozma, C. (2001). "Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. " Am J Med Genet 98(2): 168-175.
48. Kuemerle, B., Gulden, F., Cherosky, N., Williams, E. and Herrup, K. (2007). "The mouse engrailed genes: A window into autism. " Behav Brain Res 176(1): 121-132.
49. Lakatosova, S. and Ostatnikova, D. (2012). "Reelin and its complex involvement in brain development and function. " Int J Biochem Cell Biol 44(9): 1501-1504.
50. Loscher, W. (1999). "Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action. " Prog Neurobiol 58(1): 31-59.
51. Loscher, W. (2002). "Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. " CNS Drugs 16(10): 669-694.
52. MacNeil, B. M., Lopes, V. A. and Minnes, P. M. (2009). "Anxiety in children and adolescents with autism spectrum disorders. " Research in Autism Spectrum Disorders 3(1): 1-21.
53. Markram, H., Rinaldi, T. and Markram, K. (2007). "The intense world syndrome-an alternative hypothesis for autism. " Front Neurosci 1(1): 77-96.
54. Markram, K. and Markram, H. (2010). "The intense world theory-a unifying theory of the neurobiology of autism. " Front Hum Neurosci 4: 224.
55. Markram, K., Rinaldi, T., La Mendola, D., Sandi, C. and Markram, H. (2008). "Abnormal fear conditioning and amygdala processing in an animal model of autism. " Neuropsychopharmacology 33(4): 901-912.
56. Matsunami, N., Hadley, D., Hensel, C. H., Christensen, G. B., Kim, C., Frackelton, E., Thomas, K., da Silva, R. P., Stevens, J., Baird, L., Otterud, B., Ho, K., Varvil, T., Leppert, T., Lambert, C. G., Leppert, M. and Hakonarson, H. (2013). "Identification of rare recurrent copy number variants in high-risk autism families and their prevalence in a large asd population. " PLoS One 8(1): e52239.
57. McAlonan, G. M., Daly, E., Kumari, V., Critchley, H. D., van Amelsvoort, T., Suckling, J., Simmons, A., Sigmundsson, T., Greenwood, K., Russell, A., Schmitz, N., Happe, F., Howlin, P. and Murphy, D. G. (2002). "Brain anatomy and sensorimotor gating in asperger's syndrome. " Brain 125(Pt 7): 1594-1606.
58. Mehta, M. V., Gandal, M. J. and Siegel, S. J. (2011). "Mglur5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the vpa model of autism. " PLoS One 6(10): e26077.
59. Miles, J. H. and Hillman, R. E. (2000). "Value of a clinical morphology examination in autism. " Am J Med Genet 91(4): 245-253.
60. Modi, M. E. and Young, L. J. (2012). "The oxytocin system in drug discovery for autism: Animal models and novel therapeutic strategies. " Horm Behav 61(3): 340-350.
61. Moldin, S. O. and Rubenstein, J. L. R. (2006). Understanding autism: From basic neuroscience to treatment, Taylor & Francis.
62. Monteforte, R., Santillo, A., Di Giovanni, M., D'Aniello, A., Di Maro, A. and Chieffi Baccari, G. (2009). "D-aspartate affects secretory activity in rat harderian gland: Molecular mechanism and functional significance. " Amino acids 37(4): 653-664.
63. Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T. and Dean, J. C. (2000). "A clinical study of 57 children with fetal anticonvulsant syndromes. " J Med Genet 37(7): 489-497.
64. Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I. and Meesters, C. (1998). "Comorbid anxiety symptoms in children with pervasive developmental disorders. " J Anxiety Disord 12(4): 387-393.
65. Mychasiuk, R., Richards, S., Nakahashi, A., Kolb, B. and Gibb, R. (2012). "Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. " Dev Neurosci 34(2-3): 268-276.
66. Nanson, J. L. (1992). "Autism in fetal alcohol syndrome: A report of six cases. " Alcohol Clin Exp Res 16(3): 558-565.
67. Narita, M., Oyabu, A., Imura, Y., Kamada, N., Yokoyama, T., Tano, K., Uchida, A. and Narita, N. (2010). "Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. " Neurosci Res 66(1): 2-6.
68. Nau, H., Kuhnz, W., Egger, H. J., Rating, D. and Helge, H. (1982). "Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. " Clin Pharmacokinet 7(6): 508-543.
69. Ornoy, A. (2009). "Valproic acid in pregnancy: How much are we endangering the embryo and fetus?" Reprod Toxicol 28(1): 1-10.
70. Perry, W., Minassian, A., Lopez, B., Maron, L. and Lincoln, A. (2007). "Sensorimotor gating deficits in adults with autism. " Biol Psychiatry 61(4): 482-486.
71. Rasalam, A. D., Hailey, H., Williams, J. H., Moore, S. J., Turnpenny, P. D., Lloyd, D. J. and Dean, J. C. (2005). "Characteristics of fetal anticonvulsant syndrome associated autistic disorder. " Dev Med Child Neurol 47(8): 551-555.
72. Rinaldi, T., Kulangara, K., Antoniello, K. and Markram, H. (2007). "Elevated nmda receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. " Proceedings of the National Academy of Sciences 104(33): 13501-13506.
73. Rinaldi, T., Perrodin, C. and Markram, H. (2008a). "Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. " Frontiers in Neural Circuits 2.
74. Rinaldi, T., Silberberg, G. and Markram, H. (2008b). "Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. " Cereb Cortex 18(4): 763-770.
75. Rodier, P. M. (2002). "Converging evidence for brain stem injury in autism. " Dev Psychopathol 14(3): 537-557.
76. Rodier, P. M. (2004). "2003 warkany lecture: Autism as a birth defect. " Birth Defects Res A Clin Mol Teratol 70(1): 1-6.
77. Rodier, P. M., Ingram, J. L., Tisdale, B. and Croog, V. J. (1997). "Linking etiologies in humans and animal models: Studies of autism. " Reprod Toxicol 11(2-3): 417-422.
78. Rodier, P. M., Ingram, J. L., Tisdale, B., Nelson, S. and Romano, J. (1996). "Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. " J Comp Neurol 370(2): 247-261.
79. Roullet, F. I. and Crawley, J. N. (2011). "Mouse models of autism: Testing hypotheses about molecular mechanisms. " Curr Top Behav Neurosci 7: 187-212.
80. Roullet, F. I., Lai, J. K. and Foster, J. A. (2013). "In utero exposure to valproic acid and autism--a current review of clinical and animal studies. " Neurotoxicol Teratol 36: 47-56.
81. Roullet, F. I., Wollaston, L., Decatanzaro, D. and Foster, J. A. (2010). "Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. " Neuroscience 170(2): 514-522.
82. Schendel, D. E., Autry, A., Wines, R. and Moore, C. (2009). "The co-occurrence of autism and birth defects: Prevalence and risk in a population-based cohort. " Dev Med Child Neurol 51(10): 779-786.
83. Schneider, T., Labuz, D. and Przewlocki, R. (2001). "Nociceptive changes in rats after prenatal exposure to valproic acid. " Pol J Pharmacol 53(5): 531-534.
84. Schneider, T. and Przewlocki, R. (2005). "Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. " Neuropsychopharmacology 30(1): 80-89.
85. Schneider, T., Turczak, J. and Przewlocki, R. (2006). "Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: Issues for a therapeutic approach in autism. " Neuropsychopharmacology 31(1): 36-46.
86. Schneider, T., Ziolkowska, B., Gieryk, A., Tyminska, A. and Przewlocki, R. (2007). "Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. " Psychopharmacology (Berl) 193(4): 547-555.
87. Settipani, C. A., Puleo, C. M., Conner, B. T. and Kendall, P. C. (2012). "Characteristics and anxiety symptom presentation associated with autism spectrum traits in youth with anxiety disorders. " J Anxiety Disord 26(3): 459-467.
88. Silva, G. T., Le Bé, J.-V., Riachi, I., Rinaldi, T., Markram, K. and Markram, H. (2009). "Enhanced long term microcircuit plasticity in the valproic acid animal model of autism. " Frontiers in Synaptic Neuroscience 1.
89. Stanton, M. E., Peloso, E., Brown, K. L. and Rodier, P. (2007). "Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. " Behav Brain Res 176(1): 133-140.
90. Stromland, K., Nordin, V., Miller, M., Akerstrom, B. and Gillberg, C. (1994). "Autism in thalidomide embryopathy: A population study. " Developmental Medicine and Child Neurology 36: 351-356.
91. Sui, L. and Chen, M. (2012). "Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories. " Brain Res Bull 87(6): 556-563.
92. Sullivan, P. F., Daly, M. J. and O'Donovan, M. (2012). "Genetic architectures of psychiatric disorders: The emerging picture and its implications. " Nat Rev Genet 13(8): 537-551.
93. Tashiro, Y., Oyabu, A., Imura, Y., Uchida, A., Narita, N. and Narita, M. (2011). "Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: Implications for the pathogenesis of autism with multiple developmental anomalies. " Int J Dev Neurosci 29(4): 359-364.
94. van Steensel, F. J., Bogels, S. M. and Perrin, S. (2011). "Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. " Clin Child Fam Psychol Rev 14(3): 302-317.
95. Vorhees, C. V. (1987). "Behavioral teratogenicity of valproic acid: Selective effects on behavior after prenatal exposure to rats. " Psychopharmacology (Berl) 92(2): 173-179.
96. Wagner, G. C., Reuhl, K. R., Cheh, M., McRae, P. and Halladay, A. K. (2006). "A new neurobehavioral model of autism in mice: Pre-and postnatal exposure to sodium valproate. " J Autism Dev Disord 36(6): 779-793.
97. Weintraub, K. (2011). "The prevalence puzzle: Autism counts. " Nature 479(7371): 22-24.
98. Williams, E. L. and Casanova, M. F. (2011). "Above genetics: Lessons from cerebral development in autism. " Transl Neurosci 2(2): 106-120.
99. Xu, J. Y., Xia, Q. Q. and Xia, J. (2012). "A review on the current neuroligin mouse models. " Sheng Li Xue Bao 64(5): 550-562.
100. Zahir, F. R. and Brown, C. J. (2011). "Epigenetic impacts on neurodevelopment: Pathophysiological mechanisms and genetic modes of action. " Pediatr Res 69(5 Pt 2): 92R-100R.
101. Zhang, Y., Sun, Y., Wang, F., Wang, Z., Peng, Y. and Li, R. (2012). "Downregulating the canonical wnt/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. " Neurochem Res 37(7): 1409-1419.